Striatal DAT binding fully mediates caffeine’s effect on motor progression in Parkinson disease
This study demonstrates that in established Parkinson's disease, caffeine consumption accelerates the progression of rigidity and bradykinesia by downregulating striatal dopamine transporter binding, which fully mediates the adverse motor effects of caffeine.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Parkinson's disease is a condition that slowly erodes the body's ability to move with ease, turning simple actions like walking or holding a cup into difficult struggles. At the heart of this decline is a specific type of cell in the brain that produces a chemical messenger called dopamine. This chemical acts as a signal, telling muscles when to move and how to coordinate. In a healthy brain, a tiny protein on the surface of these cells, known as the dopamine transporter, acts like a vacuum cleaner, sweeping up leftover dopamine to keep the system balanced and ready for the next signal. When these cells die, the transporter disappears, the chemical signals fade, and the body stiffens or moves too slowly. For decades, scientists have looked at lifestyle habits to see if they could slow this process down. One habit in particular, drinking coffee, has long been thought to be a shield against the disease, with many studies suggesting that people who drink caffeine are less likely to develop Parkinson's in the first place.
However, a new study published in 2026 suggests that the story changes once the disease has already taken hold. Researchers from hospitals in China, working with a massive international database of patient records, investigated whether the same coffee habit that might prevent the disease could actually make it worse for those who already have it. They focused on a specific group of people: 261 patients with idiopathic Parkinson's disease and 83 healthy individuals. The team divided these people into three groups based on their coffee habits: those who currently drink caffeinated coffee, those who used to drink it but stopped, and those who never drank it at all. Using a special type of brain scan that lights up the dopamine transporters, the scientists measured how much of this "vacuum cleaner" protein remained in the striatum, a deep brain region critical for movement. They then tracked how the patients' symptoms changed over a period of one to four years.
The results revealed a surprising and complex reality. In both the healthy people and the patients with Parkinson's, those who were currently drinking coffee had significantly lower levels of the dopamine transporter in their brains compared to those who never drank it. This finding was striking because the loss of this protein is the defining feature of Parkinson's disease itself. The researchers found that the coffee drinkers' brains looked more like the brains of people with the disease than the non-drinkers did. When they looked closely at the patients' symptoms, they discovered that this drop in the transporter protein was the direct cause of worsening stiffness and slowness of movement. The study showed that the coffee did not cause the stiffness directly; rather, the coffee lowered the levels of the transporter, and that loss of the transporter is what made the stiffness and slowness worse. This chain of events was so clear that the transporter levels completely explained why coffee drinkers had more severe symptoms in these two areas.
The study also looked at how the disease progressed over time. By following the patients for up to four years, the researchers found that those who continued to drink coffee saw their stiffness and slowness get worse much faster than those who never drank coffee. The difference was measurable and significant, indicating that the daily habit was accelerating the decline in movement for these specific symptoms. Interestingly, this effect did not apply to tremors, the rhythmic shaking that is also a common symptom of the disease. The data showed no significant link between coffee intake and the worsening of tremors over time. This suggests that the shaking might be driven by different parts of the brain or different chemical pathways that are not affected by the dopamine transporter in the same way. The researchers were careful to exclude people who had stopped drinking coffee from their main analysis, as the lingering effects of past habits could have confused the results, ensuring that the findings reflected the impact of current, active consumption.
These findings challenge the long-held belief that coffee is a universal good for the brain. While it may still offer protection against developing the disease in the first place, the study indicates that for people who already have Parkinson's, continuing to drink coffee acts as a harmful factor that speeds up the loss of movement control. The authors emphasize that this does not mean coffee is a poison, but rather that its effect depends entirely on the stage of the disease. For a person with established Parkinson's, the daily cup of coffee appears to lower the brain's ability to manage dopamine, leading to a faster decline in the ability to move freely. This discovery provides a clear, biological reason why doctors might need to reconsider lifestyle advice for patients who have already been diagnosed, suggesting that what helps prevent a disease might not help, and could even hurt, someone living with it. The study offers a new, precise view of how a common daily habit interacts with the complex machinery of the brain, reminding us that in medicine, the right answer often depends on the specific moment in a person's life.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.